Chee-Ruey Hsieh received his Ph.D. in economics from Vanderbilt University in 1990. Since then, health economics has become the central focus of his research career. His first job was with the Institute of Economics, Academia Sinica, which is the most preeminent academic institution in Taiwan. He visited US universities and attended international conferences frequently. For example, he stayed at Duke University for one year as a visiting scholar between August 2005 and July 2006. Although most of his past research used empirical data obtained from Taiwan, his research focused on global issues that apply to countries all over the world. As a result, he published the majority of his research papers in international journals and has played an active role in serving as a referee for many international journals. Portions of his work have been published in the Journal of Health Economics, Journal of Human Resources, Journal of Risk and Uncertainty, Health Economics, European Journal of Health Economics, China Economic Review, Social Science and Medicine, and Value in Health. His past research has covered several diversified areas in the field of health economics and applied microeconomics, including medical malpractice, the economics of health behavior, the demand for medical care, the determinants of health, health insurance, health care expenditure, the labor supply of physicians and nurses, physician incentives, hospital competition, and the economics of the pharmaceutical industry.
After he joins the faculty members at DGHI and Duke Kunshan Unversity, he plans to expand the scope of his empirical studies to many other countries that have diversified institutional features in the delivery and financing of health care services. The major countries on his research agenda include China, India, Singapore and other countries in Southeast Asia. To be specific, he is interested in investigating how the country's health care sector responds to dynamic factors such as technological change in medicine, population aging, economic growth and the implementation of a new health insurance program. At the top of his research agenda are four specific research areas: (1) health care financing; (2) pharmaceutical policy and access to medicines; (3) the effectiveness of disease prevention strategies and policies; and (4) health care and health outcome evaluation.
Pan, J., X. Qin, and C. R. Hsieh. 2016. “Is the Pro-Competition Policy an Effective Solution for China’s Public Hospital Reform?” Health Economics, Policy and Law,11(4), 337-357.
Qin, X., S. Wang and C. R. Hsieh. 2016. “The Prevalence of Depression and Depressive Symptoms among Adults in China: Estimation Based on a National Household Survey.” China Economic Review, in Press.
Lo, T. F. and C. R. Hsieh. 2014. The Adoption of Pharmaceutical Innovation and Its Impact on the Treatment Costs for Patients with Alzheimer's Disease in Taiwan. Journal of Mental Health Policy and Economics, 17 (3), 107-117.
Qin, X. and C. R. Hsieh. 2014. Economic Growth and Geographic Maldistribution of Health Care Resources: Evidence from China, 1949-2010. China Economic Review, 31, 228-246.